Patents | Published:

Theory of knowledge and biotech patents: worlds apart?

Nature Biotechnology volume 29, pages 977978 (2011) | Download Citation

The development of original research requires tacit as well as explicit knowledge, which allows for the establishment of new epistemic trajectories with novel epistemic horizons. Much of the tacit knowledge involved in the innovation process can be transmitted as explicit knowledge through the patent document.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Nat. Biotechnol. 28, 325–328 (2010).

  2. 2.

    , , , & Econ. Policy 25, 7–59 (2010).

  3. 3.

    , & Am. Econ. Rev. 95, 461–464 (2005).

  4. 4.

    Lancet 358, 1723–1724 (2001).

  5. 5.

    Nat. Biotechnol. 28, 417–419 (2010).

  6. 6.

    World Intellectual Property Organization. WIPO Intellectual Property Handbook Policy, Law and Use (World Intellectual Property Organization, Geneva, 2004).

  7. 7.

    European Parliament and European Union Council. Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions (Official Journal of the European Communities, Brussels, 1998).

  8. 8.

    AAPS J. 9, E317–E324 (2007).

  9. 9.

    & Breakthrough! Stories and Strategies of Radical Innovation, pp. 69–70.

  10. 10.

    Arbor 184, 609–618 (2008).

  11. 11.

    Nat. Biotechnol. 28, 801–805 (2010).

  12. 12.

    Personal Knowledge (Routledge, Keagan & Paul, London, 1962).

  13. 13.

    Soc. Stud. Sci. 31, 71–85 (2001).

  14. 14.

    Redes epistémicas. Nuevos sujetos de la ciencia en nuevos modos de acción cognitiva. in La ciencia y Sus Sujetos (ed. Broncano, F. & Pérez Ransanz, A.R.) 135–158 (Siglo XXI-UNAM, México, 2009).

  15. 15.

    Nat. Biotechnol. 23, 781–783 (2005).

Download references

Acknowledgements

The authors acknowledge the funding provided to the project 068673 by Mexico's Council for Science and Technology (CONACYT) and Institute of Science and Technology of Mexico City (ICYTDF). The authors are also indebted to the Education, Research and Health Politics Unit; Research Coordination and the Research Unit of Metabolic Diseases of Mexican Institute of Social Security, Mexico City, Mexico for their support.

Author information

Affiliations

  1. Myriam M. Altamirano-Bustamante is in the Research Unit of Metabolic Diseases and the Cross-Functional Group in Clinical Ethics, Century XXI Medical Center, Mexican Institute of Social Security, Mexico City, Mexico

    • Myriam M Altamirano-Bustamante
  2. Adalberto de Hoyos is in the Cross-Functional Group in Clinical Ethics, Century XXI Medical Center, Mexican Institute of Social Security, Mexico City, Mexico, and the Institute of Philosophical Research, National Autonomous University of Mexico, Mexico City, Mexico

    • Adalberto de Hoyos
  3. León Olivé is in the Institute of Philosophical Research, National Autonomous University of Mexico, Mexico City, Mexico.

    • León Olivé

Authors

  1. Search for Myriam M Altamirano-Bustamante in:

  2. Search for Adalberto de Hoyos in:

  3. Search for León Olivé in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to León Olivé.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2026

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing